The effect of deworming on tests of tuberculosis infection in children with recent tuberculosis exposure a randomized controlled trial

Pediatric Infectious Disease Journal

Volumn 35, Issue 6, 2016, Pages 622-627

  Van Der Zalm, Marieke M ^a   Van Soelen, Nelda ^b   Mandalakas, Anna M ^a   Jacobsen, Marc ^c   Detjen, Anne K ^d   Marx, Florian M ^e,f   Grewal, Harleen M S ^g,h   Cotton, Mark F ^a   Walzl, Gerhard ^a   Hesseling, Anneke C ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF BERGEN   (Norway)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Ascaris; Children; Deworming; Helminths; QTF; TB infection; TST

Indexed keywords

IMMUNOGLOBULIN E; MEBENDAZOLE; ANTHELMINTIC AGENT; HELMINTH ANTIBODY;

ADOLESCENT; ALLERGY RAPID TEST; ARTICLE; ASCARIS LUMBRICOIDES; CHILD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEWORMING; EARLY INTERVENTION; FECES ANALYSIS; FEMALE; HELMINTHIASIS; HUMAN; IMMUNE RESPONSE; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SOUTH AFRICA; STATISTICAL ANALYSIS; TH1 CELL; THERAPY DELAY; TUBERCULIN TEST; TUBERCULOSIS; UNIVARIATE ANALYSIS; WORM EXPULSION; ANIMAL; ASCARIASIS; BLOOD; COMPLICATION; DIAGNOSTIC TEST; EVALUATION STUDY; FECES; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROSCOPY; PARASITOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ANIMALS; ANTHELMINTICS; ANTIBODIES, HELMINTH; ASCARIASIS; ASCARIS LUMBRICOIDES; CHILD; DIAGNOSTIC TESTS, ROUTINE; FECES; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERFERON-GAMMA RELEASE TESTS; MALE; MICROSCOPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84959265234     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001115     Document Type: Article

References (40)

1. WHO. Global Tuberculosis Control: WHO Report 2015. Geneva, Switzerland: World Health Organization; 2015.
2. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intrathoracic tuberculosis: A critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8:392-402.
3. Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb). 2004;84:93-101.
4. Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat Rev Immunol. 2005;5:661-667.
5. Jouanguy E, Lamhamedi-Cherradi S, Altare F, et al. Partial interferongamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest. 1997;100:2658-2664.
6. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098-1104.
7. de Silva NR, Brooker S, Hotzes PJ, Montresor A, Engels D, Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 2003;19:547-551.
8. Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367:1521-1532.
9. Preventive Chemotherapy in Human Helminthiasis, October 2006: http://www.who.int/mediacentre/news/releases/2006. Accessed November 18, 2015.
10. Jardim-Botelho A, Raff S, Rodrigues Rde A, et al. Hookworm, Ascaris lumbricoides infection and polyparasitism associated with poor cognitive performance in Brazilian schoolchildren. Trop Med Int Health. 2008;13:994-1004.
11. Saathoff E, Olsen A, Kvalsvig JD, Appleton CC. Patterns of geohelminth infection, impact of albendazole treatment and re-infection after treatment in schoolchildren from rural KwaZulu-Natal/South-Africa. BMC Infect Dis. 2004;4:27.
12. Cooper PJ, Chico ME, Sandoval C, et al. Human infection with Ascaris lumbricoides is associated with a polarized cytokine response. J Infect Dis. 2000;182:1207-1213.
13. George PJ, Anuradha R, Kumaran PP, Chandrasekaran V, Nutman TB, Babu S. Modulation of mycobacterial-specific Th1 and Th17 cells in latent tuberculosis by coincident hookworm infection. J Immunol. 2013;190:5161-5168.
14. Allen JE, Maizels RM. Diversity and dialogue in immunity to helminths. Nat Rev Immunol. 2011;11:375-388.
15. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383:787-793.
16. Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination. Clin Exp Immunol. 2001;123:219-225.
17. Resende Co T, Hirsch CS, Toossi Z, Dietze R, Ribeiro-Rodrigues R. Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin Exp Immunol. 2007;147:45-52.
18. Hesseling AC, Mandalakas AM, Kirchner HL, et al. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax. 2009;64:840-846.
19. Shanaube K, Hargreaves J, Fielding K, et al. Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa. PLoS One. 2011;6:e18206.
20. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2011;15: 1018-1032.
21. van Soelen N, Mandalakas AM, Kirchner HL, et al. Effect of Ascaris Lumbricoides specific IgE on tuberculin skin test responses in children in a high-burden setting: A cross-sectional community-based study. BMC Infect Dis. 2012;12:211.
22. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340-354.
23. Sollai S, Galli L, de Martino M, Chiappini E. Systematic review and metaanalysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: A 2013 update. BMC Infect Dis. 2014;14:S6.
24. Mandalakas AM, Kirchner HL, Walzl G, et al. Optimizing the detection of Rrecent tuberculosis infection in children in a high tuberculosis-HIV burden setting. Am J Respir Crit Care medicine. 2015;191:820-830.
25. Marais BJ, Gie RP, Hesseling AC et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics. 2006;118: 1350-1359.
26. Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Enarson NA, Beyers N. Radiographic signs and symptoms in children treated for tuberculosis: possible implications for symptom-based screening in resource-limited settings. Pediatr Infect Dis J. 2006;25:237-240.
27. Phadia AB, ed. ImmunoCAP Specific IgE Fluoroenzymeimmunoassay Calibration Range 0=100kU/l. Uppsula, Sweden: Phadia AB; 2008.
28. Mandalakas AM, Kirchner HL, Lombard C, et al. Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection. Int J Tuberc Lung Dis. 2012;16:1033-1039.
29. Kuczmarski RJ, Ogden CL, Guo SS et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2002; 246:1-190.
30. Adams VJ, Markus MB, Adams JF, et al. Paradoxical helminthiasis and giardiasis in Cape Town, South Africa: epidemiology and control. Afr Health Sci. 2005;5:276-280.
31. Graham SM, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis. 2012;205(suppl 2):S199-S208.
32. Verhagen LM, Hermans PW, Warris A, et al. Helminths and skewed cytokine profiles increase tuberculin skin test positivity in Warao Amerindians. Tuberculosis (Edinb). 2012;92:505-512.
33. Lin PL, Dartois V, Johnston PJ, et al. Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques. Proc Natl Acad Sci U S A. 2012;109:14188-14193.
34. Alsaad N, Wilffert B, van Altena R, et al. Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis. Eur Respir J. 2014;43:884-897.
35. Ryan NJ, Lo JH. Delamanid: first global approval. Drugs. 2014;74: 1041-1045.
36. Chachage M, Podola L, Clowes P, et al. Helminth-associated systemic immune activation and HIV co-receptor expression: response to albendazole/praziquantel treatment. PLoS Negl Trop Dis. 2014; 8: 2755.
37. Figueiredo CA, Barreto ML, Rodrigues LC, et al. Chronic intestinal helminth infections are associated with immune hyporesponsiveness and induction of a regulatory network. Infect Immun. 2010;78:3160-3167.
38. Dhanasekaran S, Jenum S, Stavrum R, et al. Concordant or discordant results by the tuberculin skin test and the quantiFERON-TB test in children reflect immune biomarker profiles. Genes Immun. 2014;15:265-274.
39. Jenum S, Selvam S, Mahelia D, et al. Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON(R)-TB gold in-tube in young children evaluated for tuberculosis in Southern India. Pediatr Infect Dis J. 2014;33:260-269.
40. WHO. Integrated Management of Childhood Illness; 2012.